Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future (Q43623767)

25 November 2017

0 references

Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future (English)

1 reference

primary biliary cholangitis

25 November 2017

main subject

0 references

author name string

Poupon RE

series ordinal

1

1 reference

25 November 2017

publication date

1 April 2000

1 reference

25 November 2017

published in

Journal of Hepatology

1 reference

25 November 2017

volume

32

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

685-688

1 reference

A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Serum bilirubin: a prognostic factor in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980232-9

7 January 2021

10.1016/S0168-8278(00)80232-9

Identifiers

DOI

1 reference

25 November 2017

1 reference